Related Experiment Video
Updated: Mar 21, 2026

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
Acute side effects of three commonly used gadolinium contrast agents in the paediatric population
Chris Neeley1, Michael Moritz1, Jeffrey J Brown1
1Department of Radiology, Saint Louis University School of Medicine, Saint Louis, Missouri, USA.
Insights
Gadolinium contrast agents like MultiHance, Magnevist, and Gadavist show low acute side effects in children. Sedation further reduces risks, though MultiHance had more GI symptoms without it.
Area of Science:
- Radiology
- Pediatric Imaging
- Pharmacovigilance
Background:
- Gadolinium-based contrast agents (GBCAs) are essential for pediatric imaging.
- Understanding the safety profile of different GBCAs in children is crucial for clinical practice.
Purpose of the Study:
- To evaluate and compare the incidence of acute side effects associated with three common GBCAs (MultiHance, Magnevist, Gadavist) in pediatric patients.
Main Methods:
- A retrospective review of medical records was conducted.
- The study analyzed acute adverse events in pediatric patients who received intravenous MultiHance, Magnevist, or Gadavist.
Main Results:
- Overall incidence of acute side effects was 1.7% (40/2393 patients).
- Nausea and vomiting were the most common side effects.
- Incidence was higher in non-sedated patients (2.37% vs. 0.7%).
- MultiHance showed a higher incidence of nausea and vomiting compared to Magnevist and Gadavist in non-sedated children.
Conclusions:
- MultiHance, Magnevist, and Gadavist exhibit a low incidence of acute side effects in the pediatric population.
- Sedation is associated with a reduced rate of adverse events.
- MultiHance was linked to a higher incidence of gastrointestinal symptoms compared to Magnevist and Gadavist.
Objective:
To determine the incidence of acute side effects of three commonly used gadolinium contrast agents in the paediatric population.
Methods:
A retrospective review of medical records was performed to determine the incidence of acute adverse side effects of i.v. gadolinium contrast agents [MultiHance(®) (Bracco Diagnostics Inc., Princeton, NJ), Magnevist(®) (Bayer Healthcare Pharmaceuticals, Wayne, NJ) or Gadavist(®) (Bayer HealthCare Pharmaceuticals)] in paediatric patients.
Results:
40 of the 2393 patients who received gadolinium contrast agents experienced acute side effects, representing an incidence of 1.7%. The majority of the acute side effects (in 30 patients) were nausea and vomiting. The incidence was significantly higher in non-sedated patients (2.37% vs 0.7%; p = 0.0018). Furthermore, without sedation, the incidence of both nausea and vomiting was significantly higher in children receiving MultiHance, with a 4.48% incidence of nausea when compared with Magnevist (0.33%, p < 0.0001) and Gadavist (0.28%, p < 0.0001) and a 2.36% incidence of vomiting compared with those for Magnevist (0.50%, p = 0.0054) and Gadavist (0.28%, p = 0.014), whereas no difference was observed between Magnevist and Gadavist within the power of the study. In addition, there was no apparent difference between any of the three contrast agents for the incidence of allergy or other acute side effects detected, given the sample size.
Conclusion:
The gadolinium contrast agents MultiHance, Magnevist and Gadavist have a low incidence of acute side effects in the paediatric population, a rate that is further reduced in moderately sedated patients. MultiHance demonstrated significantly increased incidence of gastrointestinal symptoms compared with Magnevist and Gadavist.
Advances In Knowledge:
The incidence of acute side effects of three commonly used gadolinium contrast agents was determined in the paediatric population, which can have clinical implications.
Related Concept Videos
Imaging Studies III: Computed Tomography
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
Radiological Investigation I: X-ray and CT
Imaging Studies for Cardiovascular System V: CT
Imaging Studies VII: Vascular Imaging
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

